Fig. 01 -

Title Slide

Fig. 02 -

TSH-Receptor Antibodies

Fig. 03 -

Epidemiology

Fig. 04 -

ATA Guidelines

Fig. 05 -

Antibody Assays

Fig. 06 -

Binding vs Bio-Assays

Fig. 07 -

Neonatal Thyrotoxicosis

Fig. 08 -

Baseline Serum

Fig. 09 -

Diagnostic Modalities

Fig. 10 -

Assay Utilization

Fig. 11 -

Cost vs Utilization Graphs

Fig. 12 -

TSAB

Fig. 13 -

TBII Assay

Fig. 14 -

TRAB and TSI

Fig. 15 -

Clinical Performance

Fig. 16 -

Function of Dilution

Fig. 17 -

6 Month levels

Fig. 18 -

Dilution Analysis

Fig. 19 -

GD During ATD

Fig. 20 -

Potential Indications

Fig. 21 -

Family Photo

Fig. 22 -

Positive Samples

Fig. 23 -

Fetal / Neonatal

Fig. 24 -

Sampling Chart

Fig. 25 -

Diagnostic Flowchart

Fig. 26 -

Stimulating and Blocking

Fig. 27 -

Correlation

Fig. 28 -

Comparison of CHO Cells

Fig. 29 -

Classification

Fig. 30 -

Positivity

Fig. 31 -

TBAb Impact

Fig. 32 -

K1-70 vs Binding

Fig. 33 -

Positive Correlation

Fig. 34 -

Summary

Fig. 35 -

Euthyroid

Fig. 36 -

Comparison of Assays

Fig. 37 -

Prevalence of TSH-R-Ab

Fig. 38 -

TSH-R-Ab Positivity

Fig. 39 -

TBAb+

Fig. 40 -

Conclusions